This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

NXUV Stock Overview

Develops and sells software solutions for the healthcare market in Germany, Switzerland, Liechtenstein, the Netherlands, Poland, France, Austria, and internationally. More details

NXUV fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	2/6
Past Performance	5/6
Financial Health	6/6
Dividends	0/6

Rewards

Earnings are forecast to grow 10.09% per year

Earnings grew by 28.2% over the past year

Risk Analysis

No risks detected for NXUV from our risk checks.

Community vs My Fair Value

Create Narrative

Select a narrative for quick price alerts from the community, or create your own.

Nexus AG Competitors

Price History & Performance

Summary of share price highs, lows and changes for Nexus
Historical stock prices
Current Share Price	€69.30
52 Week High	€70.00
52 Week Low	€54.50
Beta	0.80
1 Month Change	0.58%
3 Month Change	0.43%
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	1.46%

Recent updates

Shareholder Returns

	NXUV	DE Healthcare Services	DE Market
7D	-0.3%	-0.04%	0.5%
1Y	n/a	8.4%	15.8%

Return vs Industry: Insufficient data to determine how NXUV performed against the German Healthcare Services industry.

Return vs Market: Insufficient data to determine how NXUV performed against the German Market.

Price Volatility

Is NXUV's price volatile compared to industry and market?
NXUV volatility
NXUV Average Weekly Movement	1.5%
Healthcare Services Industry Average Movement	6.0%
Market Average Movement	6.5%
10% most volatile stocks in DE Market	12.8%
10% least volatile stocks in DE Market	3.1%

Stable Share Price: NXUV has not had significant price volatility in the past 3 months compared to the German market.

Volatility Over Time: Insufficient data to determine NXUV's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
1989	1,909	Ingo Behrendt	www.nexus-ag.de

Nexus AG develops and sells software solutions for the healthcare market in Germany, Switzerland, Liechtenstein, the Netherlands, Poland, France, Austria, and internationally. The company operates through NEXUS / DE; NEXUS / DIS; and NEXUS / ROE segments. It offers hospitals information systems, mobile solutions, digital charts and medication, PDMS and device connection, care documentation, appointment and resource management, OP management and CSSD, emergency, medical archive and VNA, patient portal, and diagnostics solutions for hospitals and clinics.

Nexus AG Fundamentals Summary

How do Nexus's earnings and revenue compare to its market cap?
NXUV fundamental statistics
Market cap	€1.20b
Earnings (TTM)	€30.82m
Revenue (TTM)	€265.52m

39.1x

P/E Ratio

4.5x

P/S Ratio

Is NXUV overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
NXUV income statement (TTM)
Revenue	€265.52m
Cost of Revenue	€189.94m
Gross Profit	€75.57m
Other Expenses	€44.76m
Earnings	€30.82m

Last Reported Earnings

Dec 31, 2024

Next Earnings Date

May 20, 2025

Earnings per share (EPS)	1.79
Gross Margin	28.46%
Net Profit Margin	11.61%
Debt/Equity Ratio	0%

How did NXUV perform over the long term?

See historical performance and comparison

Dividends

0.3%

Current Dividend Yield

13%

Payout Ratio

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/04/11 06:18
End of Day Share Price	2025/04/09 00:00
Earnings	2024/12/31
Annual Earnings	2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Nexus AG is covered by 7 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Wolfgang Specht	Berenberg
Dustin Mildner	equinet Bank AG (ESN)
Martin Possienke	GSN North America

Nexus DB:NXUV Stock Report